Human GMDS gene fragment hypermethylation in chronic high level of arsenic exposure with and without arsenic induced cancer

SpringerPlus

Volumn 2, Issue 1, 2013, Pages 1-12

  Chanda, Sarmishtha ^a,b   Dasgupta, Uma B ^a   Mazumder, Debendranath Guha ^c,d   Saha, Jayita ^b   Gupta, Bhaskar ^b  

^a UNIVERSITY OF CALCUTTA   (India)

^b PRESIDENCY UNIVERSITY   (India)

^c INSTITUTE OF POST GRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

^d DNGM Research Foundation   (India)

Author keywords

Arsenic exposure; Arsenic induced cancer; GMDS gene hypermethylation

Indexed keywords

EID: 84887275727     PISSN: None     EISSN: 21931801     Source Type: Journal    
DOI: 10.1186/2193-1801-2-557     Document Type: Article

References (48)

1. Atallah R, Kalman DA (1991) Online photooxidation for the determination of organic arsenic compounds by AAS with continuous arsine generation. Talanta 38:167-178.
2. Becker DJ, Lowe JB (2003) Fucose: biosynthesis and biological functions in mammals. Glycob 13(7):41-53.
3. Bisht KK, Dudognon C, Chang WC, Sokol ES, Ramirez A, Smith S (2012) GDP-Mannose-4,6-dehydratase is a cytosolic partner of tankyrase 1 that inhibits its poly(ADP-Ribose) polymerase activity. Mol Cell Biol 32(15):3044-3053.
4. Brenet F, Moh M, Funk P, Feierstein E, Viale AJ, Socci ND, Scandura JM (2011) DNA methylation of the first exon is tightly linked to transcriptional silencing. PLoS ONE 6(1):e14524. doi:10.1371/journal.pone.0014524.
5. Chanda S, Dasgupta UB, GuhaMazumder D, Gupta M, Chaudhuri U, Lahiri S, Das S, Ghosh N, Chatterjee D (2006) DNA hypermethylation of promoter of gene p53 and p16 in arsenic-exposed people with and without malignancy. Toxicol Sci 89:431-437.
6. Cheung HH, Davis AJ, Lee TL, Pang AL, Nagrani S, Rennert OM, Chan WY (2011) Methylation of an intronic region regulates miR-199a in testicular tumor malignancy. Oncogene 30(31):3404-3415. doi:10.1038/onc.2011.60.
7. Darnton SJ, Hardie LJ, Muc RS, Wild CP, Casson AG (2005) Tissue inhibitor of metalloproproteinase-3 (TIMP3) gene is methylated in the development of oesophageal adenocarcinoma: Loss of expression correlates with poor prognosis. Ins J Canc 115:351-358.
8. Donohue JM, Abernathy CO (2001) Arsenic methylation and the SAdenosylmethionine-mediated transmethylation/transsulfuration pathway. In: Chappel WR, Abernathy CO, Calderon RL (eds) Arsenic Exposure and Health Effects IV. Elsevier, Oxford, pp 367-379.
9. Eshel R, Besser M, Zanin A, Sagi-Assif O, Witz IP (2001) The FX enzyme is a functional component of lymphocyte activation. Cell Immunol 213:141-148.
10. Fang JY, Cheng ZH, Chen YX, Lu R, Yang L, Zhu HY, Lu LG (2004) Expression of Dnmt1, demethylase, MeCP2 and methylation of tumor-related genes in human gastric cancer. World J Gastroenterol 10:3394-3398.
11. Gaudet F, Hodgson JG, Eden A, Jackson-Grusby L, Dausman J, Gray JW, Leohardt H, Jaenisch R (2003) Induction of tumors in mice by genomic hypomethylation. Science 300:489-492.
12. Goering PL, Aposhian HV, Mass MJ, Cebrian M, Beck BD, Waalkes MP (1999) The enigma of arsenic carcinogenesis: role of metabolism. Toxicol Sci 49:5-14.
13. GuhaMazumder DN (2001) Clinical aspects of chronic arsenic toxicity. J Assoc Phys 49:650-655.
14. GuhaMazumder DN, Haque R, Ghosh N, De BK, Santra A, Chakrabarty D, Smith AH (1998) Arsenic levels in drinking water and the prevalence of skin lesions in WestBengal, India. Int J Epidemiol 27:871-877.
15. Haltiwanger RS (2009) Fucose is on the TRAIL of colon cancer. Gastroenterology 137(1):36-39.
16. Hoivik EA, Bjanesoy TE, Mai O, Okamoto S, Minokoshi Y, Shima Y, Morohashi KI, Boehm U, Bakke M (2011) DNA methylation of intronic enhancers directs tissue-specific expression of steroidogenic factor 1/adrenal 4 binding protein (SF-1/Ad4BP). Endocrinology 152(5):2100.
17. International agency for research on cancer (1997) IARC monograph on the evaluation of carcinogenic risks to humans-Overall evaluation of carcinogenicity: An update of IARC monographs 1-42., vol 7 IARC, Lyon, pp 100-106.
18. Jacobson KD, Moltanbano D (1985) The reproductive effects assessment group's report on the mutagenicity of inorganic arsenic. Environ Mutagen 7:787-804.
19. Jones PA, Baylin SB (2002) The fundamental role of epigenetic events in cancer. Nat Rev Genet 3:415-428.
20. Jowaed A, Schmitt I, Kaut O, Wullner U (2010) Methylation regulates alphasynuclein expression and is decreased in Parkinson's disease patients' brains. J Neurosci 30(18):6355-6359.
21. Kumar S, Gadagkar SR (2001) Disparity Index: A simple statistic to measure and test the homogeneity of substitution patterns between molecular sequences. Genetics 158(3):1321-1327.
22. Lee TC, Oshimura M, Barrett JC (1985) Comparison of arsenic-induced cell transformation, cytotoxicity, mutation and cytogenetic effects in Syrian Hamster embryo cell in culture. Carcinogenesis 6:1421-1426.
23. Majumder S, Chanda S, Ganguli B, Mazumder DN, Lahiri S, Dasgupta UB (2010) Arsenic exposure induces genomic hypermethylation. exposure retrieved no results. Environ Toxicol 25(3):315-8.
24. Mass MJ, Wang L (1997) Arsenic alters cytocine methylation patterns of the promoter of the tumor suppressor gene p53 in human lung cells: a model for a mechanism of carcinogenecis. Mutat Res 386:263-277.
25. Miller SS, Dykes DD, Polesky HF (1998) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res 16:1215.
26. Miyoshi E, Moriwaki K, Terao N, Tan CC, Terao M, Nakagawa T, Matsumoto H, Shinzaki S, Kamada Y (2012) Fucosylation is a promising target for cancer diagnosis and therapy. Biogeosciences 2:34-45.
27. Moriwaki K, Noda K, Furukawa Y, Ohshim K, Uchiyama A, Nakagawa T, Taniguchi N, Daigo Y, Nakamura Y, Hayashi N, Miyoshi E (2009) Deficiency of GMDS leads to escape from NK cell-mediated tumor surveillance through modulation of TRAIL signaling. Gastroenterology 137(1):188-198.
28. Moriwaki K, Narisada M, Imai T, Shinzaki S, Miyoshi E (2010) The effect of epigenetic regulation of fucosylation on TRAIL-induced apoptosis. Glycoconjugate 27(7-9):649-659.
29. Moriwaki K, Shinzaki S, Miyoshi E (2011) GMDS deficiency renders colon cancer cells resistant to TRAIL receptor and CD95 mediated apoptosis by inhibiting complex II formation. J Biol Chem 286(50):43123-43133.
30. Nakayama K, Moriwaki K, Imai T, Shinzaki S, Kamada Y, Murata K, Miyoshi E (2013) Mutation of GDP-Mannose-4,6-Dehydratase in Colorectal Cancer Metastasis. PLoS One 8(7):e70298, 10.1371/journal pone. 0070298.
31. Nandi D, Patra RC, Swarup D (2005) Effect of cysteine, methionine, ascorbic acid and thiamine on arsenic-induced oxidative stress and biochemical alterations in rats. Toxicology 211:26-35.
32. National Research Council (1999) Arsenic in Drinking water. National Academic Press, Washington DC, pp 83-149.
33. Reichard JF, Puga A (2010) Effects of arsenic exposure on DNA methylation and epigenetic gene regulation. Epigenomics 2(1):87-104. doi:10.2217/epi.09.45.
34. Ren X, McHale CM, Skibola CF, Smith AH, Smith MT, Zhang L (2010) An Emerging Role for Epigenetic Dysregulation in Arsenic Toxicity and Carcinogenesis. Environ Health Perspect, 10.1289/ehp.1002114.
35. Rossman TG, Stone D, Molina M, Troll W (1980) Absence of arsenic mutagenicity in E. coli and Chinese hamster cells. Environ Mutagen 2:371-379.
36. Saha J, Gupta K, Gupta B (2013a) A new insight into the phylogeny of vascular cryptogams with special reference to Selaginella and Isoetes inferred from nuclear ITS/5.8S rDNA sequences. J Plant Biochem Biotechnol, org/10.1007/s13562-013-0198-6.
37. Saha J, Gupta K, Gupta B (2013b) Phylogenetic analyses and evolutionary relationships of Saraca asoca with their allied taxa (Tribe-Detarieae) based on the chloroplast matK gene. J Plant Biochem Biotechnol, org/10.1007/s13562-013-0237-3.
38. Sambrook J, Fritsch EF, Maniatis T (1989) In: Nolan C (ed), vol 3, 2nd edn Molecular cloning: a laboratory manual cold spring harbor laboratory press, USA.
39. Slack A, Bovenzi V, Bigey P, Ivanov MA, Ramchandani S, Bhattacharya S, tenOever B, Lamrihi B, Scherman D, Szyf M (2002) Antisense MBD2 gene therapy inhibits tumorigenesis. J Gene Med 4:381-389.
40. Sullivan FX, Kumar R, Kriz R, Stahl M, Xu GY, Rouse J, Chang XJ, Boodhoo A, Potvin B, Cumming DA (1998) Molecular Clonning of Human GDP-mannose 4, 6-Dehydratase and Recontitution of GDP-fucose Biosynthesis in Vitro. J Biol Chem 273:8193-8202.
41. Tamura K, Nei M, Kumar S (2004) Prospects for inferring very large phylogenies by using the neighbor-joining method. Proc Natl Acad Sci U S A 101:11030-11035.
42. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S (2011) MEGA5: Molecular Evolutionary Genetics Analysis using Maximum Likelihood, Evolutionary Distance, and Maximum Parsimony Methods. Mol Biol Evol 28(10):2731-2739.
43. Thompson S, Cantwell BMJ, Matta KL, Turner GA (1992) Parallel changes in the blood levels of abnormally-fucosylated haptoglobin and alpha 1,3 fucosyltransferase in relationship to tumour burden: more evidence for a disturbance of fucose metabolism in cancer. Canc Lett 65(2):115-121.
44. Vahter M (1999) Variation in human metabolism of arsenic. In: Chappel WR, Abernathy CO, Calderon RL (eds) Arsenic Exposure and Health Effects III. Elseveir, Oxford, pp 267-275.
45. Yuan K, Listinsky CM, Singh RK, Listinsky JJ, Siegal GP (2008) Cell surface associated alpha-L-fucose moieties modulate human breast cancer neoplastic progression. Pathol Oncol Res 14(2):145-156.
46. Zhao CQ, Young MR, Diwan BA, Coogan TP, Waalkes MP (1997) Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression. Proc Natl Acad Sci 94:10907-10912.
47. Zhong CX, Mass MJ (2001) Both hypomethylation and hypermethylation of DNA associated with arsenite exposure in cultures of human cells identified by methylation-sensitive arbitrarily-primed PCR. Toxicol Lett 122:223-234.
48. Zhong CX, Wang L, Mass MJ (2001) Arsenite exposure causes both hyper and hypomethylationin human cell lines in culture at low concentrations. In: Abernathy CO, Calderon RL (eds) Chappel WR. Arsenic exposure and Health Effects IV, Elsevier, Oxford, pp 243-254.